How Big Is the Cancer Diagnostics Market | Growth Analysis 2031

Q: How big is the cancer diagnostics market?

The cancer diagnostics market was USD 134 billion in 2024 and is projected to reach USD 227 billion by 2031.

Q: What drives the growth of the cancer diagnostics market?

Increasing cancer prevalence, demand for early detection, and advanced diagnostic innovations are driving growth.

Q: What are the key trends in the cancer diagnostics market?

Non-invasive testing, AI-driven diagnostics, and personalized genomic testing are the major trends.

Q: Who are the top players in the cancer diagnostics industry?

The top players include Roche, Abbott, Thermo Fisher, GE Healthcare, and Siemens Healthineers.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA5561

Publication Date: Jul 2025

What is the size of the Cancer Diagnostics Market?

According to 6Wresearch internal database and industry insights, the Global Cancer Diagnostics Market was estimated at USD 134 billion in 2024 and is projected to reach USD 227 billion by 2031, growing at a CAGR of 6.5% during the forecast period 2025â€“2031.

Due to the rising global cancer burden, early detection initiatives, and increasing adoption of advanced diagnostic technologies across healthcare systems, the market is continued to rise in the forthcoming years.

View Main Report

Schedule Analyst Call

Key Growth Factors of the Cancer Diagnostics Market

Rising incidence of cancer and aging population
Government and private sector initiatives for early diagnosis
Advancements in biomarker research and genomic testing
Growth of non-invasive and liquid biopsy technologies
Increased awareness and screening programs worldwide

Cancer Diagnostics Market Trends

The cancer diagnostics market is moving forward with shifting towards non-invasive, rapid, and personalized testing solutions. Further, the liquid biopsies and companion diagnostics are gaining ground due to their ability to detect cancers early and guide targeted therapies. Also, the artificial intelligence is being increasingly used to enhance image-based diagnostics and streamline workflows in pathology labs.

Emerging Developments in the Cancer Diagnostics Market

Cancer diagnostics market is developing over the years with molecular diagnostics and AI-powered tools which are transforming cancer detection and classification. Liquid biopsies using circulating tumour DNA (ctDNA) are enabling real-time monitoring. Aside from these, the market started collaborating between biotech firms and diagnostics companies that is accelerating the development of multi-cancer early detection tests. These developments are enhancing the presence of the market and contributing in the expansion of the market.